◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksE › ERKA

Erika Carmel-Teck Ltd. (ERKA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Health Care · DATA UPDATED 2026-08-30

Erika Carmel-Teck Ltd. (ERKA) operates in the Health Care industry and is headquartered in חיפה, Israel with about 45 employees. Its market capitalization is roughly ₪20 million. In the fiscal year ended 2025-12-31, ERKA reported ₪37M in revenue and (₪6M) in net income.

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally.

Interactive charts & full statements → Open the ERKA valuation workbench →

ERKA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue₪37M₪38M₪30M₪49M₪106M
Gross Profit₪26M₪26M₪23M₪43M₪97M
Net Income(₪6M)(₪9M)(₪44M)(₪10M)

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

ERKA Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid₪0M₪5M

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

ERKA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets₪29M₪35M₪47M₪68M
Cash & Cash Equivalents₪4M₪7M
Total Liabilities₪19M₪26M₪37M

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ERKA viewer.

Other Companies in Health Care

This page in other languages: עברית

← ERIIAll “E” companiesERNA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.